PsycHacks Episode 426: The business of suffering (every solution needs a problem)
May 6, 2024
The podcast discusses the economic incentives behind the rise in mental illness diagnoses, focusing on how drug companies benefit from creating new disorders. It explores the reliance on medication, the inefficacy of mental health interventions in the US, and the controversy surrounding the increase in mental health diagnoses. The implications of lifetime consumption of psychiatric medication are also examined.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 2min
Psychologists vs. Psychiatrists: The Medication Divide
02:16 • 5min
Debunking the Efficacy of Mental Health Medication Interventions in the United States
07:44 • 3min
Analyzing the Growth of Mental Health Diagnoses and Screening Methods
10:59 • 2min
Exploring the Implications of Lifetime Consumption of Psychiatric Medication
12:47 • 3min